Peter Pelka
About Peter Pelka
Peter Pelka is the Clinical Operations Portfolio Lead at Bristol Myers Squibb, with over 20 years of experience in various therapeutic areas and a strong background in clinical operations management.
Current Role at Bristol Myers Squibb
Peter Pelka currently holds the position of Clinical Operations Portfolio Lead at Bristol Myers Squibb. In this role, he provides strategic operational vision and guidance to develop and execute integrated clinical study plans. His responsibilities include driving efficiency improvement strategies while maintaining the highest level of quality in clinical operations.
Previous Experience at Asana BioSciences, LLC
Before joining Bristol Myers Squibb, Peter Pelka worked as the Director of Clinical Operations at Asana BioSciences, LLC from 2018 to 2020. During his tenure, he was responsible for managing and directing clinical operations, contributing to the company's strategic goals in clinical research and development.
Educational Background
Peter Pelka has a diverse educational background that includes a Master of Science degree from Boston University, attained between 2004 and 2006. He also studied Biological Sciences at Rutgers University. Additionally, he holds a Certification in Six Sigma Lean Professional from the Management and Strategy Institute, which he achieved in 2015.
Extensive Industry Experience
With over 20 years of experience in the pharmaceutical industry, Peter Pelka has worked in various capacities across small start-ups, medium, and large pharmaceutical companies. His experience spans multiple therapeutic areas including Oncology, Anti-Infective, Cardiovascular, Hematology, CNS, Allergy, Dermatology, Renal, and Chronic Wound care. His broad expertise has equipped him to effectively manage, mentor, and develop global cross-functional teams.
Professional Journey in Clinical Operations
Peter Pelka's professional journey includes significant roles in leading clinical operations. From 2016 to 2018, he served as Director of Clinical Operations at Origin, Inc. Princeton, and had a brief stint at KBP BioSciences in a similar role. Earlier in his career, he was involved in clinical development and medical affairs roles at Shionogi Inc. and had project management responsibilities at Novo Nordisk and Johnson & Johnson.